文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

原发性硬化性胆管炎合并炎症性肠病患者结直肠异型增生与恶性肿瘤结局:需肝移植和结肠切除术的多中心研究

Colorectal dysplasia and malignancy outcomes in primary sclerosing cholangitis and inflammatory bowel disease requiring liver transplantation and colectomy: A multicenter study.
PubMed 文献 · Surgery · 2026-05-08

本研究回顾性分析9个中心50例因原发性硬化性胆管炎行肝移植、因炎症性肠病伴异型增生或恶性肿瘤行全腹结肠切除术的成人患者,比较先结肠切除与先肝移植两组的结直肠异型增生、恶性肿瘤及回肠储袋肛管吻合术结局。先肝移植组淋巴结受累更高,但两组肿瘤复发和5年总生存率相似,储袋炎发生率均为54.5%,储袋失败仅1例。

要点

  • 两组储袋炎发生率均为54.5%,储袋失败仅1例。

核心结论

  • 尽管先肝移植组患者就诊时疾病更晚期,其5年总生存率与先结肠切除组及一般文献相当。
  • 行回肠储袋肛管吻合术的患者储袋炎发生率与既往研究相似,储袋失败率低。

研究设计与样本

  • 多中心回顾性队列研究,回顾9个中心电子健康记录。
  • 纳入因原发性硬化性胆管炎行肝移植且因炎症性肠病伴异型增生或恶性肿瘤行全腹结肠切除术的成人患者,共50例。
  • 比较全腹结肠切除术先于肝移植(先结肠切除组)与肝移植先于全腹结肠切除术(先肝移植组)两组。

主要发现

  • 50例中30例因异型增生行全腹结肠切除术,20例因恶性肿瘤行全腹结肠切除术。

临床怎么用

  • 对于原发性硬化性胆管炎合并炎症性肠病需肝移植和结肠切除的患者,先肝移植组虽淋巴结受累更高,但5年总生存率与先结肠切除组相当。
  • 回肠储袋肛管吻合术后储袋炎发生率约54.5%,储袋失败率低,可据此进行术后监测与患者咨询。

局限性

  • 回顾性研究设计。
  • 样本量较小(共50例)。
  • 部分亚组分析样本量更小,统计效能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Literature guiding management of patients with primary sclerosing cholangitis and inflammatory bowel disease undergoing liver transplantation for primary sclerosing cholangitis and total abdominal colectomy for dysplasia or malignancy is limited. This study describes patterns of colorectal dysplasia, malignancy, and ileal pouch anal anastomosis outcomes for these patients. METHODS: Electronic health records from 9 centers were retrospectively reviewed. Adult patients who underwent liver transplantation for primary sclerosing cholangitis and total abdominal colectomy for inflammatory bowel disease with dysplasia or malignancy were eligible. Descriptive statistics were analyzed between 2 groups: total abdominal colectomy before liver transplantation (total abdominal colectomy first) and liver transplantation before total abdominal colectomy (liver transplantation first). RESULTS: Of 50 eligible patients, 30 underwent total abdominal colectomy for dysplasia and 20 for malignancy. Between the total abdominal colectomy first and liver transplantation first groups, there were no significant differences in malignancy as the indication for total abdominal colectomy (11 [50.0%] vs 9 [33.3%]; P= .26), T3+ disease (5 [50.0%] vs 2 [25.0%]; P= .37), or distant metastasis at the time of diagnosis (none). Nodal involvement was higher in the liver transplantation first group (5 [50.0%] vs 0 [0.0%]; P = .04). Colorectal cancer recurrence and 5-year overall survival were similar between groups (2 [18.2%] vs 2 [22.2%] and 7 [87.5%] vs 6 [75.0%]; all P= 1.0, respectively). Kaplan-Meier survival analysis showed no significant difference between the groups (P = .4). Both groups had a 54.5% rate of pouchitis. There was only 1 pouch failure. CONCLUSION: Despite more advanced disease at presentation for liver transplantation first patients, 5-year overall survival was comparable to total abdominal colectomy first patients and the general literature. Patients with ileal pouch anal anastomosis had similar rates of pouchitis to prior studies and low pouch failure.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Galloway JL, Matar AJ, Muralidharan VJ, et al. Colorectal dysplasia and malignancy outcomes in primary sclerosing cholangitis and inflammatory bowel disease requiring liver transplantation and colectomy: A multicenter study. Surgery. 2026. PMID: 42105701. doi:10.1016/j.surg.2026.110230

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。